Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families
暂无分享,去创建一个
A. Aurias | C. Griscelli | D. Stoppa-Lyonnet | N. Janin | N. Andrieu | M. Debré | M. Croquette | B. Bressac‐de‐Paillerets | A. Laugé | K. Ossian
[1] S. Seal,et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. , 1998, British Journal of Cancer.
[2] D. Easton,et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. , 1998, American journal of human genetics.
[3] K. Isselbacher,et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer , 1997, Nature Genetics.
[4] A. Børresen-Dale,et al. Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM , 1997, Genes, chromosomes & cancer.
[5] J. Hopper,et al. AT-tributable risks? , 1997, Nature Genetics.
[6] M. Swift,et al. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.
[7] M. Lovett,et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.
[8] J. Aitken,et al. How accurate is self-reported family history of colorectal cancer? , 1995, American journal of epidemiology.
[9] N. Boyd,et al. Accuracy of family cancer history in breast cancer patients , 1994, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[10] D Morrell,et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.
[11] M. Swift,et al. Cancers in 44 families with ataxia-telangiectasia. , 1990, Cancer genetics and cytogenetics.
[12] P. Møller,et al. Breast cancer and other cancers in Norwegian families with ataxia‐telangiectasia , 1990, Genes, chromosomes & cancer.
[13] A. Hall,et al. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. , 1988, Cancer research.
[14] M. Swift,et al. Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.
[15] M. Coleman,et al. Cohort study analysis with a FORTRAN computer program. , 1986, International journal of epidemiology.
[16] J. Bridgeman. Risk of breast cancer. , 1971, California medicine.
[17] T. Stankovic,et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. , 1997, British Journal of Cancer.
[18] D. Easton. Cancer risks in A-T heterozygotes. , 1994, International journal of radiation biology.
[19] J L Kelsey,et al. Breast cancer: magnitude of the problem and descriptive epidemiology. , 1993, Epidemiologic reviews.
[20] Norman E. Breslow,et al. The design and analysis of cohort studies , 1987 .
[21] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.